Gil Cohen
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Gil Cohen is currently the Vice President-Research & Development at Epitomee Medical Ltd. He previously worked as the Chief Science Officer at Dune Medical Devices Ltd. Dr. Cohen holds a doctorate degree from The Hebrew University of Jerusalem.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EPITOMEE MEDICAL LTD -.--% | 14/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EPITOMEE MEDICAL LTD | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
Dune Medical Devices Ltd.
Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Develops real-time cancer detection tools | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Dune Medical Devices Ltd.
Dune Medical Devices Ltd. Medical SpecialtiesHealth Technology Develops real-time cancer detection tools | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epitomee Medical Ltd.
Epitomee Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medical devices for obesity | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national